SitesBLAST
Comparing WP_079555937.1 NCBI__GCF_002201795.1:WP_079555937.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
3dh4A Crystal structure of sodium/sugar symporter with bound galactose from vibrio parahaemolyticus (see paper)
47% identity, 76% coverage: 45:523/631 of query aligns to 19:479/512 of 3dh4A
8hdhA Structure of human sglt2-map17 complex with canagliflozin (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 5:467/586 of 8hdhA
- binding (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (= N61), G59 (≠ E65), H60 (= H66), G63 (≠ A69), L64 (≠ M70), F78 (≠ Y84), E79 (= E85), S267 (≠ N266), W271 (= W270), F433 (= F439), D434 (≠ Q440), Q437 (= Q443)
- binding sodium ion: A53 (= A59), S54 (≠ A60), I56 (= I62), G57 (≠ S63), A369 (= A375), S372 (= S378), S373 (= S379)
Sites not aligning to the query:
- binding (2~{S},3~{R},4~{R},5~{S},6~{R})-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: 506
- binding : 575, 579, 580, 583, 584
8hb0A Structure of human sglt2-map17 complex with ta1887 (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 5:467/586 of 8hb0A
- binding (2R,3R,4S,5S,6R)-2-[3-[(4-cyclopropylphenyl)methyl]-4-fluoranyl-indol-1-yl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (= N61), H60 (= H66), G63 (≠ A69), L64 (≠ M70), T67 (≠ S73), V75 (≠ M81), F78 (≠ Y84), E79 (= E85), V137 (≠ S142), V266 (≠ T265), S267 (≠ N266), W271 (= W270), F433 (= F439), Q437 (= Q443)
- binding sodium ion: A53 (= A59), I56 (= I62), G57 (≠ S63), A369 (= A375), S372 (= S378), S373 (= S379)
Sites not aligning to the query:
7vsiA Structure of human sglt2-map17 complex bound with empagliflozin (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 5:467/586 of 7vsiA
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (= N61), H60 (= H66), G63 (≠ A69), L64 (≠ M70), V75 (≠ M81), F78 (≠ Y84), E79 (= E85), V266 (≠ T265), S267 (≠ N266), Y270 (= Y269), F433 (= F439), D434 (≠ Q440), Q437 (= Q443)
8hg7A Structure of human sglt2-map17 complex with sotagliflozin (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 5:467/590 of 8hg7A
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-oxane-3,4,5-triol: N55 (= N61), G59 (≠ E65), H60 (= H66), G63 (≠ A69), L64 (≠ M70), E79 (= E85), V266 (≠ T265), S267 (≠ N266), Y270 (= Y269), W271 (= W270), K301 (= K300), F433 (= F439), Q437 (= Q443)
- binding sodium ion: A53 (= A59), S54 (≠ A60), I56 (= I62), G57 (≠ S63), A369 (= A375), S372 (= S378), S373 (= S379)
Sites not aligning to the query:
8hezA Structure of human sglt2-map17 complex with dapagliflozin (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 5:467/582 of 8hezA
- binding (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol: N55 (= N61), G59 (≠ E65), H60 (= H66), G63 (≠ A69), L64 (≠ M70), T67 (≠ S73), F78 (≠ Y84), E79 (= E85), V266 (≠ T265), S267 (≠ N266), W271 (= W270), K301 (= K300), F433 (= F439), Q437 (= Q443)
- binding sodium ion: A53 (= A59), I56 (= I62), G57 (≠ S63), A369 (= A375), S372 (= S378), S373 (= S379)
Sites not aligning to the query:
P31639 Sodium/glucose cotransporter 2; Na(+)/glucose cotransporter 2; Low affinity sodium-glucose cotransporter; Solute carrier family 5 member 2 from Homo sapiens (Human) (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 25:487/672 of P31639
- V95 (≠ M81) mutation to A: Strong reduction in D-glucose transporter activity. Confers partial resistance to empagliflozin inhibition.
- F98 (≠ Y84) mutation to A: Slightly decreases D-glucose transporter activity. Abolishes the binding to inhibitor, empagliflozin.
- V157 (≠ S142) mutation to A: Decreases D-glucose transporter activity.
- L283 (≠ M262) mutation to M: Strong reduction in D-glucose transporter activity. Confers partial resistance to empagliflozin inhibition.
- F453 (= F439) mutation to A: Slightly decreases D-glucose transporter activity. Greatly reduces the binding to inhibitor, empagliflozin.
7wmvA Structure of human sglt1-map17 complex bound with lx2761 (see paper)
32% identity, 74% coverage: 9:473/631 of query aligns to 11:470/602 of 7wmvA
- binding N-[2-(dimethylamino)ethyl]-2-methyl-2-[4-[4-[[2-methyl-5-[(2S,3R,4R,5S,6R)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]phenyl]methyl]phenyl]butanoylamino]propanamide: N61 (= N61), H66 (= H66), L70 (≠ M70), I81 (≠ M81), F84 (≠ Y84), L257 (= L252), M266 (= M262), L269 (≠ T265), T270 (≠ N266), Y273 (= Y269), W274 (= W270), F436 (= F439), D437 (≠ Q440), Q440 (= Q443)
Sites not aligning to the query:
P13866 Sodium/glucose cotransporter 1; Na(+)/glucose cotransporter 1; High affinity sodium-glucose cotransporter; Solute carrier family 5 member 1 from Homo sapiens (Human) (see 6 papers)
32% identity, 74% coverage: 9:473/631 of query aligns to 28:487/664 of P13866